Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Takeaways for Dermatologists GIP and GLP-1 receptor agonists like tirzepatide and semaglutide offer promising anti-inflammatory benefits, particularly for overweight patients with psoriasis, HS, and AD Understanding the role of visceral fat in systemic inflammation can help dermatologists appreciate the broader impact of weight management on skin health Dermatologists should consider integrating GLP-1 receptor agonists into treatment plans where appropriate Ongoing research will further elucidate the role of GLP-1 receptor agonists in dermatology, potentially paving the way for new treatment paradigms.
Got a specific injury (tendon, muscle, joint)
We understand life happens, with our busy schedule we make others our priority while putting ourselves last
A girl named Sam is not playing
